PREGNANCY AND RENAL TRANSPLANTATION

Area of Science:

• Nephrology
• Obstetrics
• Transplantation Immunology

Background:

• Medical and surgical advancements have increased the incidence of pregnancy in female kidney transplant recipients.
• Pregnancy in this population presents significant risks to both the mother and the transplanted kidney (allograft).
• Fertility often returns quickly post-transplant, making contraception a critical consideration in the first year.

Purpose of the Study:

• To review the risks and management strategies for pregnancy in kidney transplant patients.
• To highlight potential complications and emphasize the need for specialized care.
• To provide guidance on immunosuppression, delivery, and breastfeeding.

Main Methods:

• Review of current medical literature and clinical guidelines regarding pregnancy in kidney transplant recipients.
• Analysis of risks associated with allograft function, maternal medical conditions, and fetal outcomes.
• Discussion of immunosuppressive drug modifications and delivery considerations.

Main Results:

• Pregnancy can compromise allograft function, particularly with pre-existing hypertension, significant kidney disease, or proteinuria.
• Increased prevalence of medical complications including infections, gestational diabetes, hypertension, and anemia.
• Concerns for adverse fetal outcomes such as low birth weight and preterm delivery.
• Risk of acute allograft rejection necessitates vigilant monitoring and appropriate immunosuppression.
• Specific immunosuppressants like mycophenolic acid and sirolimus are contraindicated due to teratogenicity.

Conclusions:

• Pregnant kidney transplant patients require a multidisciplinary approach within a tertiary care setting.
• Continuation of essential immunosuppression is vital, with careful avoidance of teratogenic agents.
• Vaginal delivery is preferred, with Cesarean section reserved for obstetric indications.
• Breastfeeding is permissible for mothers on corticosteroid therapy.
• Kidney donors can experience safe pregnancies with awareness of potential risks like gestational hypertension and diabetes.
• Establishment of registries is essential for data collection and addressing unresolved questions in this high-risk group.